clinical trial · NCT05869773
A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy
NarcolepsyJZP258
brief summary
The aim of this study is to quantify the change in blood pressure when participants with narcolepsy treated with high-sodium oxybate are transitioned to Xywav, a low-sodium oxybate. The results of this study may provide health care providers (HCPs), patients, and payers with important new information regarding BP changes related to differences in sodium content between available oxybates for the treatment of narcolepsy.
started
Jun 26, 2023
primary completion
Feb 25, 2025
completion
Mar 10, 2025
last updated
Apr 24, 2026
official title
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to Xywav
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol